Tinelli, MichelaRyan, MandyBond, Christine2016-08-022016-08-022016-07-29Tinelli, M, Ryan, M & Bond, C 2016, 'What, who and when? Incorporating a discrete choice experiment into an economic evaluation', Health Economics Review, vol. 6, 31. https://doi.org/10.1186/s13561-016-0108-42191-1991http://hdl.handle.net/2164/6307Acknowledgements The Medman study was funded by the Department of Health for England and Wales and managed by a collaboration of the National Pharmaceutical Association, the Royal Pharmaceutical Society of Great Britain, the Company Chemist Association and the Co-operative Pharmacy Technical Panel, led by the Pharmaceutical Services Negotiating Committee. The research in this paper was undertaken while the lead author MT was undertaking a doctoral research fellowship jointly funded by the Economic and Social Research Council (ESRC) and the Medical Research Council (MRC). The Health Economics Research Unit (HERU), University of Aberdeen is funded by the Chief Scientific Office of the Scottish Government Health and Social Care Directorate.9748755engSDG 3 - Good Health and Well-beingeconomic evaluationdiscrete choice experiment (DCE)willingness to pay (WTP)quality adjusted life year (QALY)cost-benefit analysis (CBA)randomised controlled trial (RCT)R MedicineEconomic and Social Research Council (ESRC)Medical Research Council (MRC)Chief Scientist Office (CSO)Supplementary DataRJournal article10.1186/s13561-016-0108-46